Following the recent transfer of DSM's global caprolactam business activities into a JV named ChemicaInvest with CVC Capital Partners, DSM Caprolactam will be renamed as Fibrant effective January 18, 2016.
DSM Caprolactam is a global leader and the only producer active in three key consuming regions of China, USA and Europe.Following the recent transfer of DSM's global caprolactam business activities into a JV named ChemicaInvest with CVC Capital Partners, DSM#
The company has a total caprolactam production capacity of more than 900,000 metric tons per annum and over 1,500,000 metric tons of ammonium sulfate, while sales stood at €1,700 million in 2014.
Established in 1952, DSM Caprolactam, a fully owned subsidiary of DSM, joined ChemicaInvest in July 2015 as an offshoot of DSM.
“Using its unique technology, based on its own proprietary HPO process, the company produces high quality caprolactam and ammonium sulfate from locations in China, USA and Netherlands,” a press release said.
Executive chairman Sheu said, “For more than 60 years we have led the world in the development of caprolactam technology and process improvement.”
“With our new name and visual identity, Fibrant pays homage to its heritage serving the nylon industry and the fibres market and the name reflects our vibrant future and chemistry between the company and its partners,” he added.
Sheu further pointed out that the new logo emblem contains an abstract version of the unique HPO reactor system.
Fibrant, which will be headed by CEO Pol Deturck said, “We build on a strong heritage of more than 60 years, with a proven track record as a responsible and reliable producer of high quality products and services.”
“It is my vision that Fibrant will act as a market leader in shaping the industry dynamics in the coming years, serving customers directly in their home markets, through our unique global network,” Deturck noted.
On July 31, 2015, CVC and DSM announced that they had finalised their partnership for DSM's activities in Polymer Intermediates like caprolactam and acrylonitrile and also composite resins under the JV company.
These activities have been brought under the ownership of ChemicaInvest, which is 65 per cent owned by CVC and 35 per cent by DSM.
In 2014, ChemicaInvest's activities comprised 1,950 employees, pro-forma third party sales of €2.1 billion and EBITDA of €106 million. (AR)
Fibre2Fashion News Desk – India
.jpg?tr=w-120,h-60,c-at_max,cm-pad_resize,bg-ffffff "UBM China (Shanghai)")
-Ltd..jpg?tr=w-120,h-60,c-at_max,cm-pad_resize,bg-ffffff "Thermore (Far East) Ltd.")
